Health Tips
Provigil vs Wakix (pitolisant): newer narcolepsy options
For most of the last century, a person with narcolepsy had two real choices: an amphetamine-type stimulant or living with the sleepiness. Then, in early August 2026, the FDA approved Orzeyful (oveporexton), the first drug that acts on the orexin system that narcolepsy type 1 actually breaks. That news has a lot of people looking again at the medicines they already take, and the Provigil vs Wakix question is one of the most common. Provigil (modafinil) has been around since 1998. Wakix (pitolisant) arrived in 2019 and has picked up new uses almost every year since.
Below: a quick timeline, then the two drugs side by side on cataplexy, scheduling, age limits, speed, side effects, interactions, and trial results. Your sleep specialist makes the final call.
Short answer: Provigil and Wakix both treat excessive daytime sleepiness in narcolepsy, but they work on different brain chemicals. Wakix is also FDA-approved for cataplexy, is not a controlled substance, and is approved for children 6 and older. Provigil is a Schedule IV drug for adults only, works from the first dose, and has more than 25 years of real-world use. Neither is clearly “stronger” for sleepiness: the one head-to-head trial did not prove Wakix was as good as modafinil, but it did not show a meaningful gap either.
Then vs now: a timeline of narcolepsy treatment
To see why the Provigil vs Wakix comparison matters, it helps to see how slowly things moved and then how fast they sped up. The table below lists the main US milestones. Dates are FDA approval dates unless noted.
| Year | Milestone | What it changed |
|---|---|---|
| 1935 onward | Amphetamines first reported for narcolepsy sleepiness | Strong stimulants became the default for decades; methylphenidate later joined them |
| 1998 | Provigil (modafinil) | First “wakefulness-promoting agent”; milder than amphetamines and Schedule IV rather than Schedule II |
| 2002 | Xyrem (sodium oxybate), for cataplexy | First drug aimed at cataplexy and disrupted night sleep; EDS use added in 2005 |
| 2007 | Nuvigil (armodafinil) | Longer-lasting relative of modafinil |
| 2019 | Sunosi (solriamfetol) in March; Wakix (pitolisant) in August | Two new mechanisms for daytime sleepiness; Wakix is not a controlled substance |
| 2020 | Xywav (lower-sodium oxybate), July; Wakix approved for adult cataplexy, October | About 92% less sodium than sodium oxybate; first daytime pill with a cataplexy label |
| 2023 | Lumryz (once-nightly sodium oxybate), May | No 2 a.m. alarm for a second dose |
| 2024 | Wakix approved for EDS in children 6 and older, June | First non-scheduled pediatric option for sleepiness |
| 2026 | Wakix approved for cataplexy in children 6 and older, February; Orzeyful (oveporexton) for adults with narcolepsy type 1, early August | First orexin receptor 2 agonist, aimed at the root cause of type 1 |
From 1998 to 2019, the only new options were modafinil, armodafinil, and oxybate. Since 2019 the list has roughly doubled, and Provigil went from default first pill to one choice among several.
For a fuller look at modafinil’s own role in narcolepsy care (dosing, how it is started, how long people stay on it), see our Provigil for narcolepsy guide. This post sticks to the comparison.
Modafinil vs pitolisant: two different ways to stay awake
Narcolepsy weakens the brain’s wake signals. Provigil and Wakix boost two different ones.
Provigil: more dopamine in the gaps between nerve cells
The FDA label says modafinil’s exact mechanism is not fully known. What is known is that it binds to the dopamine transporter, the “recycling pump” that pulls dopamine back into nerve cells. Blocking that pump leaves more dopamine active, which pushes the brain toward alertness. That is a gentler version of what stimulants do, which is why modafinil comes up so often in comparisons like Provigil vs Adderall.
Wakix: taking the brakes off histamine
Histamine is not just the allergy chemical. In the brain, it is one of the main wake signals, which is why old allergy pills like diphenhydramine make you drowsy. Your brain has a built-in brake on histamine release called the H3 receptor. Pitolisant is an H3 antagonist/inverse agonist, meaning it blocks that brake and also turns down its background activity. More histamine is released, and histamine in turn nudges other wake chemicals. The label, like Provigil’s, says the exact mechanism in narcolepsy is unclear.
Because the two drugs pull different levers, someone who does poorly on one may still do well on the other. It also explains why sedating antihistamines can blunt Wakix.
Wakix for cataplexy: the clearest difference
Cataplexy is a sudden loss of muscle tone, often set off by laughter or surprise, in narcolepsy type 1. It ranges from a slack jaw to a full collapse while fully awake.
Here the Provigil vs Wakix gap is plain. Wakix is FDA-approved to treat cataplexy in adults (since October 2020) and in children 6 and older (since February 2026). Provigil is approved only to improve wakefulness. It is not labeled for cataplexy, and most sleep specialists do not expect it to help much with cataplexy on its own.
The evidence for Wakix in cataplexy comes mainly from the HARMONY CTP trial (Szakacs and colleagues, Lancet Neurology, 2017). In 105 to 106 adults with frequent attacks, weekly cataplexy fell by about 75% on pitolisant versus about 38% on placebo over seven weeks. The FDA label reports this as a rate ratio of 0.51, which roughly means half as many attacks as placebo. In the pediatric trial, the cataplexy subgroup also had fewer attacks than placebo.
Before Wakix, adults with cataplexy mostly relied on nighttime oxybate or off-label antidepressants, so a daytime pill with a cataplexy label was a real addition.
Is Wakix a controlled substance? Scheduling compared
No. Wakix is not scheduled by the DEA. The AASM describes it as the first and only FDA-approved non-scheduled narcolepsy treatment for both adults and children, with or without cataplexy. Provigil is a Schedule IV controlled substance, the same category as armodafinil and Sunosi.
What that means day to day:
- Refills: Schedule IV prescriptions have limits on refills and how long a prescription stays valid. Non-scheduled drugs follow normal prescription rules.
- Misuse risk: Modafinil’s risk of misuse is lower than that of amphetamines, but it is not zero. Wakix’s non-scheduled status reflects that animal and human studies did not show a meaningful abuse signal.
Non-scheduled does not mean “mild.” Wakix still has heart rhythm and interaction warnings. Every medicine in this post should be taken only as prescribed, stored out of reach, never shared, and dropped off at a pharmacy or DEA take-back site when no longer needed.
Who can take each: Wakix for children with narcolepsy vs Provigil for adults
The Provigil label says it is not approved in children for any use. It is approved for adults with excessive sleepiness from narcolepsy, obstructive sleep apnea (as an add-on to CPAP or other airway treatment), or shift work disorder. The AASM 2021 guideline gives modafinil only a conditional recommendation in children with narcolepsy, based on very low-quality evidence, and notes serious skin reactions that have been reported in kids.
Wakix is approved for excessive daytime sleepiness or cataplexy in people with narcolepsy who are 6 years and older. The pediatric approval rests on a placebo-controlled trial of 110 young people aged 6 to 17. Wakix is narcolepsy only. It is not approved for sleep apnea or shift work disorder, which Provigil is.
Consider an illustrative case: a 12-year-old with type 1, heavy sleepiness, and cataplexy when she laughs, whose family would rather avoid a controlled drug. On the label alone, Wakix fits; her heart rhythm, other medicines, and response still decide.
How fast each works: titration and the waiting period
This is the difference that surprises people most when they switch.
Provigil: one dose, same day
The label’s usual adult dose for narcolepsy is 200 mg once in the morning, and your prescriber decides what is right for you. People typically feel it within an hour or two, and the effect lasts much of the day. Our posts on how long modafinil takes to kick in and how long Provigil lasts cover the timing in detail.
Wakix: a slow climb
Wakix is started low and stepped up. For adults, the label lays out a three-week ramp: a starting dose in week 1, a higher dose in week 2, and an option to reach the maximum in week 3. Children follow a four-week ramp, with a lower ceiling for those under 40 kg. Lower maximum doses apply to people who process the drug slowly (CYP2D6 “poor metabolizers”) and to those with moderate liver or reduced kidney function.
The label notes some patients take up to eight weeks to respond fully. Someone used to Provigil working on day one may feel Wakix “isn’t doing anything” in week two and quit too soon, so agree on a trial period with your doctor first.
Tip: Keep a simple one-line daily log during any switch: hours of good alertness, naps needed, and (if you have type 1) cataplexy episodes. It turns “I think it’s working?” into something you and your sleep doctor can actually compare at follow-up. Do not change doses or stop either drug on your own.
Wakix side effects vs Provigil side effects
Headache tops both lists. Percentages below come from each FDA label’s placebo-controlled trials, which used different patients, so treat them as a rough guide.
| Side effect | Provigil (vs placebo) | Wakix, adults (vs placebo) |
|---|---|---|
| Headache | 34% (23%) | 18% (15%) |
| Nausea | 11% (3%) | 6% (3%) |
| Insomnia | 5% (1%) | 6% (2%) |
| Anxiety | 5% (1%) | 5% (1%) |
| Nervousness | 7% (3%) | Not listed separately |
| Upper respiratory infection / rhinitis | Rhinitis 7% (6%) | 5% (3%) |
| Back or musculoskeletal pain | Back pain 6% (5%) | 5% (3%) |
| Diarrhea | 6% (5%) | Not in main table |
| Faster heart rate | Not in main table | 3% (0%) |
| Decreased appetite | Not in main table | 3% (0%) |
| Hallucinations | Not in main table | 3% (0%) |
In children taking Wakix, the most common side effects were headache (19%) and insomnia (7%). Taking Wakix on waking, as the label directs, helps keep it from disturbing sleep.
The serious warnings differ. Provigil’s label warns about rare but dangerous skin reactions, including Stevens-Johnson syndrome, and says to stop at the first sign of a rash unless it is clearly unrelated. It also warns about psychiatric symptoms and advises caution with some heart conditions. Wakix’s main warning is QT prolongation, a change in the heart’s electrical rhythm. Post-marketing reports for Wakix include depression and suicidal thoughts, though a causal link is not established.
Call 911 or go to the ER for fainting, a racing or pounding heartbeat with dizziness, chest pain, a seizure, trouble breathing, swelling of the face or throat, or a rash with blisters, peeling skin, or mouth sores. Call your prescriber promptly for any new rash on Provigil, or for new depression, agitation, or thoughts of self-harm on either drug.
Interactions, including Wakix and birth control
Both drugs can make hormonal birth control fail
This is the shared warning that matters most for women. Both medicines speed up a liver enzyme (CYP3A4) that breaks down the hormones in the pill, patch, ring, and some implants. That can lower hormone levels enough for pregnancy to happen.
- Provigil: effectiveness of steroidal contraceptives may drop during use and for one month after stopping. The label advises a backup or alternative method.
- Wakix: the label advises switching to a non-hormonal method during treatment and for at least 21 days after stopping.
Ask your prescriber which methods are reliable for you. Our Provigil and birth control guide goes deeper on this. Wakix also has a pregnancy exposure registry (1-800-833-7460) for anyone who becomes pregnant while taking it.
Wakix-specific issues: QT, CYP2D6, and antihistamines
- QT-prolonging drugs: avoid Wakix with other medicines that stretch the QT interval (some antibiotics, antipsychotics, antiarrhythmics, and others), and in people with known QT prolongation, a history of arrhythmia, or low potassium or magnesium.
- Strong CYP2D6 inhibitors (for example, some antidepressants such as paroxetine, fluoxetine, or bupropion): these roughly double Wakix levels, and the label says to cut the Wakix dose in half.
- Strong CYP3A4 inducers (such as rifampin or carbamazepine): these cut Wakix levels about in half, and a dose change may be needed.
- Sedating antihistamines that reach the brain may blunt Wakix’s effect.
- Liver: Wakix is not for people with severe liver impairment.
Provigil-specific issues
Modafinil can lower levels of drugs like cyclosporine (CYP3A4) and raise levels of drugs like phenytoin, diazepam, and omeprazole (CYP2C19). The label suggests closer INR checks with warfarin. Give your pharmacist your full list, including over-the-counter aids.
What the trials showed in Provigil vs Wakix
Few narcolepsy drugs have been compared head to head. Wakix and modafinil are an exception, which makes this the most data-driven part of the Provigil vs Wakix debate. The results are more mixed than either side’s fans tend to admit.
HARMONY 1: the direct comparison
HARMONY 1 (Dauvilliers and colleagues, Lancet Neurology, 2013) randomized 95 adults with narcolepsy to pitolisant, modafinil, or placebo for eight weeks. Both drugs beat placebo on the Epworth Sleepiness Scale, a self-rated sleepiness score. The researchers also tested whether pitolisant was “noninferior,” meaning no more than 2 points worse than modafinil. The average difference between the two drugs was tiny (about 0.12 points), but the confidence range was wide, so noninferiority was not formally shown.
Put simply: close, but too small to prove pitolisant was not meaningfully worse. A second trial, HARMONY 1bis, used lower pitolisant doses and also did not establish noninferiority, according to the European regulators’ review summarized by NICE.
HARMONY CTP and the pediatric trial
HARMONY CTP also showed better sleepiness and wakefulness test scores than placebo, but had no modafinil arm. The pediatric trial beat placebo on sleepiness in ages 6 to 17.
What the guidelines say
The American Academy of Sleep Medicine’s 2021 guideline gives a strong recommendation to both modafinil and pitolisant for adults with narcolepsy, alongside sodium oxybate and solriamfetol. It does not rank them against each other. In practice, that means the choice turns on your symptoms, other conditions, and preferences, not on one drug being “the best.”
Wakix for idiopathic hypersomnia: not approved
Idiopathic hypersomnia (IH) is a different sleep disorder with constant sleepiness, long sleep times, and severe trouble waking up. Harmony Biosciences asked the FDA to add IH to Wakix’s label, but in February 2025 the company announced the FDA had refused to file the application, meaning the agency declined to review it. The phase 3 INTUNE study had missed its main sleepiness goal. Harmony has said it plans to study a higher-dose version of pitolisant for IH instead.
So, as of October 2026, Wakix is not FDA-approved for IH, though the AASM guideline lists pitolisant as a conditional off-label option. Modafinil is not approved for IH either, but the guideline strongly recommends it there.
Where Orzeyful (oveporexton) fits among new narcolepsy medications in 2026
In narcolepsy type 1, the brain has lost most of the cells that make orexin (also called hypocretin), a chemical that holds wakefulness steady and keeps REM sleep features like muscle paralysis out of the daytime. Every drug discussed so far works around that loss. Orzeyful is the first approved medicine that directly activates orexin receptor 2, essentially standing in for the missing signal.
Here is what is known from the approval reports:
- Who it is for: adults with narcolepsy type 1 only. It is not approved for type 2 (narcolepsy without cataplexy) or for children.
- Evidence: two 12-week phase 3 trials, FirstLight and RadiantLight, with 273 participants. Compared with placebo, people on oveporexton stayed awake much longer on the Maintenance of Wakefulness Test, reported much less sleepiness, and had far fewer cataplexy attacks.
- Common side effects: insomnia (very common), urinary urgency and frequency, and excess saliva.
- Scheduling: controlled-substance scheduling was pending DEA review at approval, and the drug was expected to launch after that decision. Check the current label for its status.
Orzeyful’s reported effects look larger than older Provigil or Wakix trials, but those are different studies, there are no head-to-head data, and long-term experience is limited. For children, adults with type 2, and people doing well now, Provigil and Wakix remain the main daytime options. Sunosi is the other common comparison; see our Provigil vs Sunosi breakdown.
Combining treatments: a prescriber-led decision
Many people with narcolepsy end up on more than one medicine. A common pattern is a nighttime oxybate plus a daytime wake drug. Some sleep specialists combine Wakix with modafinil when neither alone is enough. The FDA label notes that in a study of healthy adults, pitolisant did not meaningfully change blood levels of modafinil or sodium oxybate, which is reassuring on that one point.
Still, two drugs that both weaken birth control and both can cause insomnia need a doctor’s oversight. Never add leftover or borrowed pills to your regimen. Good sleep habits and planned naps also stay part of the plan; our overview of why sleep matters for health explains the basics.
Provigil vs Wakix: which might suit whom
This table reflects label facts and common reasoning in sleep medicine. It is a starting point for a talk with your doctor, not a decision tool.
| Situation | Often leans toward | Why |
|---|---|---|
| Child or teen (6 to 17) with narcolepsy | Wakix | FDA-approved at 6+ for sleepiness and cataplexy; Provigil is not approved for children |
| Adult with frequent cataplexy who wants a daytime pill | Wakix (or ask about Orzeyful for type 1) | Wakix has a cataplexy label; Provigil does not |
| Prefers or needs a non-controlled drug | Wakix | Not DEA-scheduled; Provigil is Schedule IV |
| Needs relief right away | Provigil | Works from day one; Wakix takes weeks to build up |
| Also has sleep apnea or shift work disorder | Provigil | Approved for those; Wakix is narcolepsy only |
| Known long QT, arrhythmia, or on QT-prolonging drugs | Usually Provigil (with heart review) | QT prolongation is Wakix’s main warning |
| Takes a strong CYP2D6-blocking antidepressant | Either, with adjustment | Wakix dose must be halved; modafinil has its own CYP2C19 issues |
| Did not respond to the other one | The other one | Different mechanisms; failing one does not predict failing the other |
If you are weighing modafinil against stimulants as well, our comparisons of modafinil vs Adderall and modafinil vs Vyvanse cover that ground. And if your doctor is considering armodafinil, see Nuvigil vs Provigil.
Frequently asked questions
Is Wakix better than Provigil for daytime sleepiness?
Not clearly. In the HARMONY 1 trial, both beat placebo and the average difference between them was very small, but the study was too small to prove pitolisant was as good as modafinil. The AASM strongly recommends both for adults. Which works better for you depends on your body, other medicines, and whether cataplexy is part of your picture.
How long does Wakix take to start working?
Wakix is stepped up over about three weeks in adults and four in children. Some people notice changes during the ramp, but the label says full response can take up to eight weeks. That is very different from Provigil, which most people feel on the first day. Agree on a fair trial period with your prescriber before deciding it is not working.
Can I take Wakix and Provigil together?
Some sleep specialists do combine them, and a study found pitolisant did not meaningfully change modafinil blood levels. But combining raises the chance of insomnia, anxiety, and contraceptive failure, and needs a heart and medicine review. Only do this under your prescriber’s direction. Do not add one to the other on your own.
Does Wakix make birth control less effective?
Yes. Wakix can lower the effectiveness of hormonal contraceptives such as the pill, patch, and ring. The label advises using a non-hormonal method during treatment and for at least 21 days after stopping. Provigil has a similar warning that lasts one month after stopping. Ask your prescriber or pharmacist which methods are reliable with your medicines.
Why isn’t Wakix a controlled substance when Provigil is?
Controlled status reflects how likely a drug is to be misused. Modafinil acts partly on dopamine, the brain’s reward chemical, and showed some misuse potential, so it is Schedule IV. Pitolisant works through histamine and did not show a meaningful abuse signal in testing, so it was not scheduled. It still needs a prescription and has real safety warnings.
Can Wakix be used for idiopathic hypersomnia?
It is not FDA-approved for idiopathic hypersomnia. In February 2025, Harmony announced the FDA refused to file its application for that use after the main trial missed its primary goal. The AASM guideline lists pitolisant as a conditional option for IH, so a doctor may prescribe it off-label, but insurance may not cover it.
Should I switch to Orzeyful instead of Provigil or Wakix?
Orzeyful is approved only for adults with narcolepsy type 1, and it is very new. Its trial results looked strong, but it has not been compared directly with Provigil or Wakix, and its controlled-substance status was still pending at approval. If you have type 1 and are not doing well, ask your sleep specialist whether it makes sense for you.
My child takes Wakix. What should I watch for?
In the pediatric trial, headache and trouble sleeping were the most common side effects. Give it in the morning as directed. Call the prescriber about fainting, a racing heartbeat, mood changes, or new medicines, including allergy pills and antibiotics, since some interact. Keep it locked away and never let siblings or friends take it.
The takeaway on Provigil vs Wakix
Narcolepsy treatment has changed more since 2019 than in the two decades before, and the Provigil vs Wakix choice sits in the middle of that shift. Provigil offers fast, familiar relief from sleepiness for adults, with a Schedule IV label and a rash warning. Wakix takes weeks to build up but adds cataplexy coverage, approval for children 6 and older, and no controlled-substance status, with QT and interaction cautions of its own. Both weaken hormonal birth control. Orzeyful now offers adults with type 1 a new kind of option. Bring your symptom log and full medicine list to your sleep specialist and decide together. Never stop or change either drug suddenly on your own.
This article is for education only and is not medical advice. Do not start, stop, or change any medicine without talking to your prescriber. Provigil (modafinil) is a Schedule IV controlled substance that should only be used with a valid prescription, exactly as directed, and never shared. Wakix (pitolisant) is not a controlled substance but is still prescription-only and should never be shared. Store all medicines locked up and dispose of unused tablets through a pharmacy or DEA take-back program. If someone has chest pain, fainting, a seizure, or a severe skin reaction, call 911 right away.
Sources
- WAKIX (pitolisant) tablets prescribing information, revised February 2026 (FDA)
- PROVIGIL (modafinil) tablets prescribing information (FDA Label database)
- Maski K, et al. Treatment of central disorders of hypersomnolence: an AASM clinical practice guideline. J Clin Sleep Med. 2021;17(9):1881-1893 (PubMed)
- NICE Evidence Summary ES8: Narcolepsy with or without cataplexy in adults: pitolisant (evidence review of HARMONY 1, HARMONY 1bis, HARMONY CTP)
- American Academy of Sleep Medicine: FDA approves Wakix for cataplexy in pediatric narcolepsy (February 2026)
- NeurologyLive: FDA refuses to file Harmony’s supplemental NDA for pitolisant in idiopathic hypersomnia (February 2025)
- Healio: FDA approves Orzeyful for type 1 narcolepsy in adults (August 2026)
- American Academy of Sleep Medicine: FDA approves Xywav to treat narcolepsy (July 2020)
- NeurologyLive: FDA approves once-nightly formulation of sodium oxybate (Lumryz) to treat narcolepsy (May 2023)
- Swick TJ. Narcolepsy 101: Past, Present, Future (Narcolepsy Network)
- Dauvilliers Y, et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial (HARMONY 1). Lancet Neurol. 2013 (cited via NICE ES8; no direct link)
- Szakacs Z, et al. Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy (HARMONY CTP). Lancet Neurol. 2017 (cited via NICE ES8 and the Wakix label; no direct link)